Sigma Labs, Inc. (OTCMKTS:SGLB) Falls in Mid-Week Carnage

Sigma Labs, Inc. (OTCMKTS:SGLB), the 3D printing wonder, seems to be less wondrous these days. The stock retreated to 8 cents from recent heights on two days of accelerated selling. The drop came despite the news that SGLB secured a $1.2 million private placement. The ticker slid down more than 24% on Wednesday, on selling volumes above $1.6 million. SGLB0725.png

SGLB has made a steady and regular climb since 2012, and now stands at a peak, on days with record volumes. This created worries among investors that the company is burning through cash a bit too fast, despite the promise of the 3D printing industry. Also, the promotional effort for this ticker is wearing out, the last email dated as far back as July 8th.BCYP0724.png

Before the new cash injection, SGLB held:

  • $194,481 cash
  • $517,561 total assets
  • $106,407 total liabilities
  • $164,264 quarterly revenue
  • $196,616 net loss

The above results brought some jitters, as SGLB did not stand very stable at 11 cents, and understandably, corrected soon afterward. However, the company is an active communicator and might compensate the fall with enough enticing press releases. And now there are 120 million shares in the wild, acquired at one cent- a great incentive for insider selling that could bring this ticker down to its lows.

Several tickers that survived the carnage on Monday made a mid-week correction, despite the high hopes. One of those was Novus Robotics, Inc. (OTCMKTS:NRBT), which made a dramatic reversal of fortunes as investors considered 25 cents ripe for the picking, and wiped out 10 cents of the price.

Blue Calypso, Inc. (OTCBB:BCYP) also switched direction mid-week, for a small correction.

SGLB may still talk about its long-term potential, and a pumper could boost activity if another email is spread. Still, the current levels are highly dependent on press releases and the hype surrounding 3D printing. While the company may finally prove itself with a sought-after marketable product, a correction is never out of question, so it is best to remain alert and not invest unaffordable sums.

You may also like...